March 24, 2016 - 2:08 PM EDT
Print Email Article Font Down Font Up
Portage Biotech Inc. Files SEC Form 6-K, Report of Foreign Issuer [Rules 13A-16 And 15D-16] (Mar. 14, 2016)

By a News Reporter-Staff News Editor at Biotech Week -- According to news reporting originating from

Washington, D.C.
, by NewsRx journalists, a U.S. Securities and Exchange Commission (SEC) filing by Portage Biotech Inc. (Form 6-K) was posted on March 14, 2016.

The SIC code for this company is 1311, Crude Petroleum and Natural Gas.

The SEC file number is 0001095435-16-000046.

The contact information for this company is 47 AVENUE ROAD, SUITE 200,

TORONTO
A6 M5R 2G3, 416-929-1806.

Our editors provided additional information about Form 6-K: This report is used by certain foreign private issuers to furnish information: (i) required to be made public in the country of its domicile; (ii) filed with and made public by a foreign stock exchange on which its securities are traded; or (iii) distributed to security holders. The report must be furnished promptly after such material is made public. The form is not considered "filed" for Section 18 liability purposes. This is the only information furnished by foreign private issuers between annual reports, since such issuers are not required to file on Forms 10-Q or 8-K.

A U.S. Securities and Exchange Commission filing is a formal document or financial statement submitted to the SEC by publicly-traded companies.

For additional information on this SEC filing see: http://www.sec.gov/Archives/edgar/data/1095435/0001095435-16-000046-index.html.

Keywords for this news article include: Biotechnology, Energy, Oil & Gas, SEC Filing, Portage Biotech Inc., Crude Petroleum and Natural Gas.

Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2016, NewsRx LLC

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer


Source: Equities.com News (March 24, 2016 - 2:08 PM EDT)

News by QuoteMedia
www.quotemedia.com

Legal Notice